Latest Glenmark pharmaceuticals News
Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to
Innovative Immuno-Oncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma
Glenmark Pharmaceuticals Ltd. (Glenmark) a research-led, global pharmaceutical…
Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to
Advance Treatment of Hematological Malignancies
Glenmark Pharmaceuticals Ltd. (Glenmark) a research-led, global pharmaceutical…
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
Glenmark Launches Vancomycin Hydrochloride for Injection in the…
